Feda Azab

6.6k citations
84 papers · 5.6k · 2 hit papers · h-index 30

Impact in

  • Hematology top 0.5%
    • Multiple Myeloma Research and Treatments
  • Genetics top 1%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Multiple Myeloma Research and Treatments 42
    • Chronic Lymphocytic Leukemia Research 35

Feda Azab

81 papers receiving 5.5k citations

Feda Azab's Hit Papers

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy 2015 · 1.7k citations
1.7k0+4+8Years since publication5001k1.5k

Peers

Feda Azab
Comparison fields: 5 of 104
  • Hematology 1.4k
  • Genetics 766
  • Cancer Research 951
  • Oncology 672
  • Molecular Biology 1.4k
Replace Abdel Kareem Azab with:
Abdel Kareem Azab United States
Antonio Sacco United States
Ruben D. Carrasco United States
Dmitri Wiederschain United States
Scott J. Dylla United States
Aru Narendran Canada
Ajeeta B. Dash United States
Mark A. Schroeder United States
P. Nagesh Rao United States
Emmet McCormack Norway
Feda Azab relative to Abdel Kareem Azab United States Abdel Kareem Azab's profile →
Citations per field
00.5×1.5×
Abdel Kareem Azab · 1×
Citations per year

Countries citing papers authored by Feda Azab

Since Specialization
Citations

This map shows the geographic impact of Feda Azab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feda Azab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feda Azab more than expected).

Fields of papers citing papers by Feda Azab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feda Azab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feda Azab. The network helps show where Feda Azab may publish in the future.

Co-authors

The 25 scholars most cited alongside Feda Azab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Feda Azab Line = papers co-authored together Feda Azab links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
Hit paper breakdown →
20151656
2
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
Hit paper breakdown →
2013693
3 2009370
4 2009271
5 2012267
6 2012135
7 2009128
8 2015121
9 2011107
10 2010104
11 2008101
12 200999
13 200898
14 201398
15 200894
16 201093
17 200985
18 201073
19 200870
20 201170

About Feda Azab

Feda Azab is a scholar working on Hematology, Genetics, Cancer Research, Oncology and Molecular Biology, having authored 84 papers that have together received 5.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (42 papers), Chronic Lymphocytic Leukemia Research (35 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Chemokine receptors and signaling (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), MicroRNA in disease regulation (2 papers), Extracellular vesicles in disease (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (766 citations), Cancer Research (951 citations), Oncology (672 citations) and Molecular Biology (1.4k citations). Feda Azab has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Abdel Kareem Azab, Barbara Muz, Pilar de la Puente, Irene M. Ghobrial, Aldo Maria Roccaro, Antonio Sacco, Patricia Maiso, Hai T. Ngo, Kenneth Carl Anderson and Judith M. Runnels. Their work appears in journals such as Blood, Clinical Cancer Research, Blood Cancer Journal, Molecular Cancer Research and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact